A manifesto for the future of ICU trials
- PMID: 33298134
- PMCID: PMC7724445
- DOI: 10.1186/s13054-020-03393-5
A manifesto for the future of ICU trials
Conflict of interest statement
Not applicable.
References
-
- Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA J Am Med Assoc. 2019;321(20):2003–2017. doi: 10.1001/jama.2019.5791. - DOI - PMC - PubMed
-
- Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, Cooney E, Mikkelsen ME, Kerlin MP, Small DS, Halpern SD. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189(12):1469–1478. doi: 10.1164/rccm.201401-0056CP. - DOI - PMC - PubMed
-
- RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 2020;17:NEJMoa2021436. 10.1056/NEJMoa2021436. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
